5AM Ventures - Unicorn Nest

5AM Ventures

5AM Ventures

This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Headquarters Location

United States, Menlo Park

About

5AM Ventures is the renowned VC, which was created in 2002. The fund is located in United States, North America. The main office of this VC is situated in Menlo Park.

The fund has no an exact preference in the amount of founders of companies in its portfolio. When a start-up has 5+ founders, the probability of closing the deal is low. Audentes Therapeutics, Ikaria, Relypsa are amongst the various portfolio companies of this fund. The country of its establishment and the country of its most frequent investments coincides - United States. However, start-ups from 5 other countries can be found in the fund's portfolio. We can highlight the most popular investment areas for this fund, such as Life Science, Therapeutics. In addition, there are 12 more industries where it has achieved success. The average start-up age at the time of investment by this fund is 4-5.

The fund usually invests in rounds together with 4-5 others. Along with 5AM Ventures, start-ups are often financed by Clarus Ventures, ARCH Venture Partners, Sprout Group as well as 47 other investors. The fund often co-invests with Roche Venture Fund, Frazier Healthcare Partners, Clarus Ventures, overall with 85 funds from our list. The investors in the following rounds are usually ARCH Venture Partners, Roche Venture Fund, Aravis Ventures, and 70 VCs in total.

The fund was established by Andrew Schwab, John Diekman. Besides the listed founders, we have found 8 key employees of this fund in our database.

5AM Ventures is involved in 8 percentage points less than the average amount of lead investments when compared with other funds. The fund's activity peaked in 2018. In addition, the fund was active in 2019. The most exits for the fund occurred in 2018. When 5AM Ventures invests, the average start-up valuation is 10-50 millions dollars. The fund typically enters into 7-12 deals annually. The fund performance shows that this VC achieves 12 percentage points more exits in comparison to other VCs. Typical investments for this fund are deals in the range of 10 - 50 millions dollars.

Year Founded

2002

Fund Activity

Operative

Mail Rule [rules by which you can get an email of an interesting for you fund employee, knowing only the name and surname of this employee]

Domain name: 5amventures.com; User name format in descending order of probability: first, first_initial last, first '.' last

Group Appearance [how often fund is operating separately from groups with shared interest]

100.0% of cases

Investments per Year [average amount of rounds in which fund participates each year]

7-12

Follow-on Index [how often fund is ready to support its portfolio startup at next rounds]

43.1% of cases

Average Multiplicator [the average ratio of the last valuation of portfolio startups to their total amount of financing raised]

x6.5

Average Portfolio Company
Exit Age [the average age of portfolio startups at which they go public or become acquired]

1.4 years

Success / Strategy Similarity
Index [the matching between fund's investment strategy and its proved successes in the form of portfolio startups high valuations]

0.39 out of 1

Number of Unicorns [amount of portfolio companies, which were valuated at more then $1B]

3

Funds Investing in Previous
Rounds

Clarus Ventures, ARCH Venture Partners, Sprout Group

Funds Investing in Following
Rounds

ARCH Venture Partners, Roche Venture Fund, Aravis Ventures

If you have found a spelling error or the data isn't actual, please, notify us by selecting that text and pressing Ctrl+Enter.

Fund reviews
  • No reviews are submitted yet.
Crunchbase icon

Content report

The following text will be sent to our editors: